Pillar IIReduced FMD risk to EUFMD Members from European

neighbourhood

Progress report: UPDATE September 2018 – January 2019

97th Executive Committee meeting31 Jan – 1 Feb 2019

1.Progression along PCP2.Improve assessment of risk3.Implementation of risk basedstrategies4. Improved national capacity forFMD management

Targets across the pillar

Turkey and Transcaucasus• Two workshops on outbreak investigation were carried out in

collaboration with GDFC for 50 participants from East provinces ofTurkey (Nov and Dec 2018).

– Clinical surveillance

– FMD outbreak investigation

– FMD clinical management

• Following a workshop on FMD surveillance and post-vaccinationmonitoring (May 2018) an immunogenicity study was designed andstarted in November in Georgia and Azerbaijan in collaboration withIZSLER and SAP institute.

21 January 2019

Online meeting for North Africa on FMD and PPR

ObjectivesShare and discuss the national epi-situation, the implemented measures to manage the outbreaks and to prevent spreadIdentify needs that international and regional partners could support

North Africa

29 october 2018, Italy

II. Open session side event (WS) : managethe risk and achieve progressive control in NorthAfrica

Outcomes

Tunisia

• Implemented Measures• Activation of national crisis management• Borders surveillance reinforcement / Ring vaccination around outbreaks• Vaccination campaign planned for January 2019

• Needs• Financial support for 2 additional FMD vaccination on bovine only (Sept 2019 and Sept 2020)• Lab support (diagnostic kits / international FMD samples shipment )

24/12/2018 (OIE, 2018) 10/01/2019 (OIE, 2019) 22/01/2019 (OIE, 2019)

• 12 Outbreaks reported in identified high risk areas for FMD – detected in non vaccinated animals or vaccinated more than 6-8 months ago / farms with new introductions/ areas with low vaccination coverage

• Serotype O confirmed - ongoing sequencing (ANSES)

• Annual vaccination campaign with >6PD50 vaccine March 2018 :• LR : O3039, O manisa, SAT2 Eri, AIrq22

• SR: O3039, O manisa, SAT2 Eri

Outbreaks started in 15/12/2018

• Implemented Measures• Rising surveillance levels in animal contact points • Outbreak management (culling before sept 18 /disinfection / compensation) • SR Ring vaccination (320.000 SR vaccinated)• Animal movement control• Feb 2019– start PPR vaccination campaign ; March 2019 FMD vaccination• Temporary stop of animal import • KITS and PCR support from EuFMD is ready to be provided

• Serotype O confirmed (Pirbright / Anses ) : O EA3

• LR vaccination Oct 2018 (74% coverage) : >6PD50 O/A vaccine (O Manisa + O 3039 / A 22 Irak)

Outbreaks started in June 2018

Sept 2018 – Jan 2019 : FMD-PPR in SR + FMD in LRJune- sept 18 : 103 FMD outbreaks in LR

Algeria

n =36 wilayasn= 28 wilayas

• Serotype O confirmed , pending sequencing (ANSES )• 5 outbreaks in 3 provinces (including 1 in the North linked

by animal commercial movement with live animal market in the first affected region).

• Clinical FMD in non vaccinated LR and SR (young animals)• Outbreaks occurred in the defined high-risk areas

Outbreaks started on 1st Jan 2019

Morocco

• Major implemented Measures for Emergency management :• Activation of the national emergency response plan• culling of all susceptible animals compensation and

disinfection• LR ring vaccination (3647 cattle vaccinated in 465 flocks)• Strict application of emergency response plan measures,

including biosecurity measures

• Preventive vaccination campaign annually conducted for large ruminants. The last implemented started 28 Dec 2018 (O / A high potency vaccine)

Online meeting - recommendations:

• Ensure strict biosecurity measures when carrying out

vaccination campaigns

• Conduct a technical workshop for the three countries on

post-vaccination monitoring as part of EuFMD support for

the REMESA Action Plan.

• Better use of the risk information collected and analysed

(ref: animal mobility)

• Schedule meetings between the three countries on regular

basis

How to ensure that GF-TADs process is applied in North Africa ?

(Importance of provide indicators of progress and addressed gaps)

Lebanon (obj: assist RBSP development) – next WS plannedin April

Results:

Formulation of FMD taskforce.

Agreement on the vision and goals of the RBSP.

Agreement on conducting national NSP survey

Agreement the appropriate ways to collect the dataneeded to finalize the situation analysis

Jordan (obj: assist M&E of RBSP – next WS planned in May)

Results

Plan for training 210 trainees (public , private vets andpara-vets.)

Two peripheral labs have been equipped with ELISA andPCR units and training for 20 lab vets planned

New reporting and surveillance system and new draftlegislation to support RBSP activities

Revision of M/E indicators

Mission in Beirut, Lebanon - Amman, Jordan - Cairo, Egypt (Dec 2018)

Middle East

Workshop on Post Vaccination Monitoring in Egypt,Cairo, 14 - 17 January 2019

1. To discuss current approaches on FMDvaccination and PVM.

2. To build capacity on evaluating FMDvaccination and post-vaccination monitoring.

3. To strengthen networking among all partieswho are involved on FMD vaccination andPVM in Egypt.

4. Designing and drafting of the sero-surveillance plan.

18 participants from each of the following departments:

• Seven participants from (GOVS)

• Three participants ( AHRI)

• Three Participants from (CLEVB)

• Three Participants from (VSVRI)

• One Participant from (MEVAC)

• One Participant from (IFT)

Recommendations

(i) Evaluation of immunity and level of protection through small scale efficacy studies combined with data about coverage.

(ii) Increasing the PD50 of the vaccine/s used from 3 to 6.

(iii) Adopt a different vaccination time schedule (every six months rather than every 4 months as done at present) with a complete primary course vaccination with a booster dose after 1 month.

(iv) Target the population to be vaccinated based on a two criteria (geographical area + production sector) and not a mass vaccination approach as currently adopted.

FMD Investigation Training

course in Arabic (Dec 2018)

250 participants from 14 countries

Priorities and opportunities in the future programme for integration of efforts for risk reduction of FAST diseases

Priority: early warning and better preparedness forFMD and Similar TADs in the EU neighbourhood -integrated approach

Opportunities:- building on networks established- making use of the horizontal approach- adopting flexible programme- working with partners

1. Coordinated activities

To achieve progressive control of FAST:

- Coordinated mechanism with other institutions (regularupdates of FMD control strategies and definition of prioritiesand related workplans)

- Coordination with countries to support national programmeswith regional/sub-regional meetings and national activities

2. Improved early warning:

- Collection and analysis of risk information

- Definition of hot spot locations

- Design surveillance

- Prioritization of vaccines and improve their availability

North Africa (Algeria, Mauritania) and most countries inWest Africa have reported an epizootic of FMD in the2018, with closely related strains of serotype O (EA-3topotype)

Sufficient attention should be given to deliver on theinitiatives on livestock prices, movements and riskmapping in these areas.

FMD in West and North Africa

3. Capacity building:

- Laboratory capacity / network

- Vet Serv. capacity (e.g. clinical investigation, surveillance and control)

- Application of OIE code

FMD Risk assessment along the value chain

FMD Post Vaccination Monitoring

FMD Socio-economic Impact Assessment

Safe Trade and FMD Control

Networks (between EURLs and NRL)

E.g. of curses developed with potential for

wider application

Progressive control

Early warning

Capacity building

Trainings

Emergency preparedness:

CP – AESOP / PRAGMATIST Better use of

expertise and budget